lansoprazole has been researched along with Anemia, Hemolytic in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, T | 1 |
| Hayashi, T | 1 |
| Nonaka, Y | 1 |
| Hirano, M | 1 |
| Nomura, T | 1 |
| Miyazawa, I | 1 |
| Ishikawa, F | 1 |
| Kakiuchi, T | 1 |
1 other study available for lansoprazole and Anemia, Hemolytic
| Article | Year |
|---|---|
[A case of hemolysis induced by lansoprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anemia, Hemolytic; Anti-Ulcer Agents; Humans; Lansoprazole; | 1996 |